Loading...
Loading...
News corpora, social media analysis, movie/music metadata, sports data, cultural datasets, misinformation
9,815 datasets
The Teslin flood hazard mapping study provides geospatial data and reports detailing flood risks for the Teslin area in Yukon, Canada. The study was completed between May 2023 and October 2024 by the Government of Yukon. It includes GIS data files and flood maps for three specific annual exceedance probability scenarios.
Flood hazard maps for Carmacks, Yukon, produced by the Government of Yukon. The mapping study was completed between April 2023 and May 2024. The maps depict flood scenarios for three Annual Exceedance Probability (AEP) levels: 0.5%, 1%, and 5%.
The Dawson City/Klondike Valley flood hazard mapping study was completed by the Government of Yukon between May 2024 and March 2026. It includes GIS data files and flood maps modeling three flood scenarios: 0.5%, 1%, and 5% Annual Exceedance Probability (AEP) events. Resources include a project summary, technical report, and community feedback report.
Flood hazard maps for Old Crow, Yukon, were completed between April 2024 and May 2025. The maps model three flood scenarios: a 0.5% (1-in-200), 1% (1-in-100), and 5% (1-in-20) annual exceedance probability event. The dataset includes GIS files, technical reports, and summary documents published by the Government of Yukon.
Completed between November 2022 and April 2024, this dataset contains flood hazard maps for the Southern Lakes region of Yukon, Canada. The maps model flood scenarios for 0.5%, 1%, and 5% Annual Exceedance Probability events. The dataset includes GIS data files, technical reports, and summaries from the Government of Yukon.
Upper Liard flood hazard maps were produced by the Government of Yukon between May 2025 and March 2026. The dataset includes GIS data files, flood maps, and technical reports modeling three flood scenarios based on Annual Exceedance Probability (AEP). Resources are available under the OGL-CA-2.0 license.
A systematic review and meta-analysis evaluating wearable overground exoskeleton-assisted therapy for people with cerebral palsy. The review, conducted by Nicola Postol and following PRISMA guidelines, analyzed 21 studies with 241 participants. It found statistically significant improvements in walking endurance, balance, speed, and high-level mobility post-intervention.
A systematic review and meta-analysis of 15 studies with 1,756 participants, published up to August 2025, investigates the DTI-ALPS index as a biomarker for glymphatic dysfunction in Alzheimer's disease. The dataset, authored by Zulin Liao and shared under a CC-BY-4.0 license, contains pooled results showing a stepwise decrease in ALPS values across cognitively normal controls, mild cognitive impairment, and Alzheimer's disease groups. The analysis was conducted according to PRISMA guidelines and registered with PROSPERO.
Qin Zhang's dataset contains 450 valid survey responses from international students in China, collected to study cross-cultural consumption behavior. The data was used to test a structural equation model analyzing pathways from perceived value to purchase intention. The dataset was last updated on 2026-05-29.
A 2026 systematic review and meta-analysis by Jiemei Chen, aggregating data from 19 studies involving 591 patients. The dataset compiles clinical outcomes, including cure and improvement rates, pad test results, leakage frequency, and quality-of-life scores, to evaluate the efficacy and safety of autologous regenerative cell therapy for female stress urinary incontinence.
Jiemei Chen published a meta-analysis of 19 clinical studies involving 591 patients on figshare in June 2026. The dataset compiles clinical outcomes for autologous regenerative cell therapy for female stress urinary incontinence. It reports pooled cure and improvement rates, symptom changes, quality of life scores, urodynamic parameters, and adverse events.
A meta-analysis of 19 clinical studies involving 591 patients evaluating autologous regenerative cell therapy for female stress urinary incontinence. The analysis, conducted by Jiemei Chen, reports pooled cure and improvement rates and assesses secondary outcomes including pad tests and quality of life scores. The dataset was last updated on June 3, 2026.
A meta-analysis of four propensity score-matched studies comparing surgical outcomes for proximal advanced gastric cancer. The dataset includes 589 patients (284 proximal gastrectomy, 305 total gastrectomy) treated with neoadjuvant chemotherapy. It was authored by Yueping Li and last updated on June 2, 2026.
Hui Zhao's supplementary document from a systematic review and meta-analysis on the efficacy of acupuncture for depression-associated chronic pain. The review includes 10 randomized controlled trials involving 761 participants, with data analyzed up to March 2025. The file, last updated in June 2026, contains the full review methodology, results, and conclusions.
A systematic review and meta-analysis by Hui Zhao, published on figshare in June 2026, synthesizes evidence from 10 randomized controlled trials involving 761 participants. The analysis compares the efficacy and safety of acupuncture versus conventional medication for treating depression-associated chronic pain. It includes meta-regression and sensitivity analyses performed using Stata15.1.
A 2026 systematic review and meta-analysis by Esma Nur Kolbaşı, aggregating data from 10 randomized controlled trials involving 420 stroke patients with a mean age of 59.6 years. The study evaluates the combined effects of active noninvasive brain stimulation (NIBS) and constraint-induced movement therapy (CIMT) on motor impairment and functional ability. Findings suggest low-certainty evidence for modest improvements in upper extremity motor impairment.
A systematic review and meta-analysis of 12 real-world cohort studies investigating the effect of GLP-1 receptor agonists on advanced liver outcomes in adults with type 2 diabetes. The primary pooled estimate from four active-comparator studies was a hazard ratio of 0.85 (95% CI 0.74–0.98) for incident cirrhosis or serious liver events. Authored by Jing-Hong Hu and last updated in June 2026, the work is registered with PROSPERO (CRD420261299499) and shared under a CC-BY-4.0 license.
Twelve comparative real-world cohort studies form the basis of an exploratory meta-analysis on GLP-1 receptor agonists and advanced liver outcomes in adults with type 2 diabetes. The data, compiled by Jing-Hong Hu, includes a primary pooled hazard ratio estimate and was last updated in June 2026. This systematic review emphasizes active-comparator designs and clinically advanced liver endpoints, with evidence identified through a focused search of PubMed/MEDLINE and Embase.
A systematic review and meta-analysis of real-world cohort studies investigating the association between glucagon-like peptide-1 receptor agonists (GLP-1RAs) and advanced liver outcomes in adults with type 2 diabetes. The work by Jing-Hong Hu, published on figshare in 2026, includes 12 eligible comparative studies, with a primary pooled hazard ratio estimate of 0.85 for serious liver events. The evidence is rated as very low certainty due to the observational nature of the included studies.
A systematic review and exploratory meta-analysis of 12 comparative real-world cohort studies investigating the association between glucagon-like peptide-1 receptor agonists (GLP-1RAs) and advanced liver outcomes in adults with type 2 diabetes. The work was authored by Jing-Hong Hu and published on figshare in June 2026 under a CC-BY-4.0 license. The primary pooled estimate from four active-comparator studies was a hazard ratio of 0.85 for incident cirrhosis or composite serious liver events.